288 related articles for article (PubMed ID: 24056144)
1. Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics.
Tsai M; Lu Z; Wientjes MG; Au JL
J Control Release; 2013 Dec; 172(3):737-44. PubMed ID: 24056144
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo correlation of paclitaxel-loaded polymeric microparticles.
Park K
J Control Release; 2013 Dec; 172(3):1162. PubMed ID: 24315459
[No Abstract] [Full Text] [Related]
3. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading.
Lee WL; Guo WM; Ho VHB; Saha A; Chong HC; Tan NS; Tan EY; Loo SCJ
Acta Biomater; 2015 Nov; 27():53-65. PubMed ID: 26340886
[TBL] [Abstract][Full Text] [Related]
4. Microparticles produced by the hydrogel template method for sustained drug delivery.
Lu Y; Sturek M; Park K
Int J Pharm; 2014 Jan; 461(1-2):258-69. PubMed ID: 24333903
[TBL] [Abstract][Full Text] [Related]
5. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded poly(D,L-lactide-co-glycolide) nanoparticles for radiotherapy in hypoxic human tumor cells in vitro.
Jin C; Bai L; Wu H; Liu J; Guo G; Chen J
Cancer Biol Ther; 2008 Jun; 7(6):911-6. PubMed ID: 18367873
[TBL] [Abstract][Full Text] [Related]
7. Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel.
Tsai M; Lu Z; Wang J; Yeh TK; Wientjes MG; Au JL
Pharm Res; 2007 Sep; 24(9):1691-701. PubMed ID: 17447121
[TBL] [Abstract][Full Text] [Related]
8. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
Kim SC; Kim DW; Shim YH; Bang JS; Oh HS; Wan Kim S; Seo MH
J Control Release; 2001 May; 72(1-3):191-202. PubMed ID: 11389998
[TBL] [Abstract][Full Text] [Related]
9. Versatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer.
Au JL; Lu Z; Wientjes MG
AAPS J; 2015 Sep; 17(5):1065-79. PubMed ID: 26089090
[TBL] [Abstract][Full Text] [Related]
10. The anti-melanoma efficiency of the intratumoral injection of cucurbitacin-loaded sustained-release carriers: a PLGA particle system.
Jianbo G; Xue L; Hongdan Y; Zhaohui T; Xing T; Chenchen C; Jinghua X; Hui X
J Pharm Sci; 2013 Aug; 102(8):2550-63. PubMed ID: 23729371
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
[TBL] [Abstract][Full Text] [Related]
12. Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation.
Wang J; Ng CW; Win KY; Shoemakers P; Lee TK; Feng SS; Wang CH
J Microencapsul; 2003; 20(3):317-27. PubMed ID: 12881113
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded microparticles for intratumoral administration via the TMT technique: preparation, characterization, and preliminary antitumoral evaluation.
Hamoudeh M; Diab R; Fessi H; Dumontet C; Cuchet D
Drug Dev Ind Pharm; 2008 Jul; 34(7):698-707. PubMed ID: 18612910
[TBL] [Abstract][Full Text] [Related]
14. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
Mu L; Feng SS
J Control Release; 2003 Jan; 86(1):33-48. PubMed ID: 12490371
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
16. Activity of drug-loaded tumor-penetrating microparticles in peritoneal pancreatic tumors.
Lu Z; Tsai M; Wang J; Cole DJ; Wientjes MG; Au JL
Curr Cancer Drug Targets; 2014; 14(1):70-8. PubMed ID: 24200079
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell membrane-camouflaged poly(lactic-co-glycolic acid) microparticles as a potential controlled release drug delivery system for local stellate ganglion microinjection.
Liu B; Zhang D; Tu H; Alimi OA; Kong Y; Satyanarayana R; Kuss M; Li Y; Duan B
Acta Biomater; 2023 Apr; 161():201-212. PubMed ID: 36858164
[TBL] [Abstract][Full Text] [Related]
18. The intracellular uptake of CD95 modified paclitaxel-loaded poly(lactic-co-glycolic acid) microparticles.
Ateh DD; Leinster VH; Lambert SR; Shah A; Khan A; Walklin HJ; Johnstone JV; Ibrahim NI; Kadam MM; Malik Z; Gironès M; Veldhuis GJ; Warnes G; Marino S; McNeish IA; Martin JE
Biomaterials; 2011 Nov; 32(33):8538-47. PubMed ID: 21824652
[TBL] [Abstract][Full Text] [Related]
19. Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model.
Amoozgar Z; Wang L; Brandstoetter T; Wallis SS; Wilson EM; Goldberg MS
Biomacromolecules; 2014 Nov; 15(11):4187-94. PubMed ID: 25251833
[TBL] [Abstract][Full Text] [Related]
20. Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance.
Gupta R; Shea J; Scafe C; Shurlygina A; Rapoport N
J Control Release; 2015 Aug; 212():70-7. PubMed ID: 26091919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
